[CONSIDERATIONS ON TREATMENT WITH LIVER-PROTECTIVE DRUGS IN LIVER DYSFUNCTIONAL STATES CAUSED BY FATIGUE IN ATHLETES].
D064751:Ammonium Compounds; D056352:Athletes; D003401:Creatine; D003404:Creatinine; D005221:Fatigue; D006801:Humans; D007294:Inositol; D008099:Liver / Q000502:physiology*; D008107:Liver Diseases; D008110:Liver Extracts; D009525:Niacin; D009536:Niacinamide; D010205:Pantothenic Acid; D020011:Protective Agents; D000644:Quaternary Ammonium Compounds; D013178:Sports Medicine; D014805:Vitamin B 12; D014803:Vitamin B Complex
D064751:Ammonium Compounds; D008110:Liver Extracts; D020011:Protective Agents; D000644:Quaternary Ammonium Compounds; D014803:Vitamin B Complex; D010205:Pantothenic Acid; D009536:Niacinamide; D009525:Niacin; D007294:Inositol; D003404:Creatinine; D003401:Creatine; D014805:Vitamin B 12
AMMONIUM COMPOUNDS; CREATINE AND CREATININE; FATIGUE; INOSITOL; LIVER EXTRACTS; LIVER FUNCTION; NICOTINAMIDE; PANTOTHENIC ACID; SPORT MEDICINE; VITAMIN B 12
CONSIDERAZIONI SULLA TERAPIA CON EPATOPROTETTORI NEGLI STATI DISFUNZIONALI EPATICI DA AFFATICAMENTO NEGLI SPORTIVI.